Volume 15, Issue 5 (August 2021)
Qom Univ Med Sci J 2021, 15(5): 322-333 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rastgarian A, Kalani N, Esmaealpour N, Estakhr M, Ghotbi Z, Jalali M. Awareness of Patients With MS From Covid 19: A Cross-sectional Descriptive Study on the Second Wave of Coronavirus in Jahrom City. Qom Univ Med Sci J 2021; 15 (5) :322-333
URL: http://journal.muq.ac.ir/article-1-3214-en.html
URL: http://journal.muq.ac.ir/article-1-3214-en.html
Ahmad Rastgarian1 
, Navid Kalani2 , Nafiseh Esmaealpour3 , Mehrdad Estakhr4 , Zahra Ghotbi4 , Maryam Jalali * 5
, Navid Kalani2 , Nafiseh Esmaealpour3 , Mehrdad Estakhr4 , Zahra Ghotbi4 , Maryam Jalali * 5
1- Department of Anesthesiology, School of Medicine, Anesthesiology and Pain Control Research Center, Jahrom University of Medical Sciences, Jahrom, Iran.
2- Department of Health Services Management, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.
3- Department of Nursing, Clinical Research Development Unit, Peymanieh Hospital, Jahrom University of Medical Sciences, Jahrom, Iran.
4- Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
5- Department of Neurology, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran. ,jalalimaryam66@yahoo.com
2- Department of Health Services Management, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.
3- Department of Nursing, Clinical Research Development Unit, Peymanieh Hospital, Jahrom University of Medical Sciences, Jahrom, Iran.
4- Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
5- Department of Neurology, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran. ,
Abstract: (2085 Views)
Background and Objectives: Patients with multiple sclerosis, especially those treated with immunosuppressive drugs, are less immune than normal individuals and may be more susceptible to Covid 19. The aim of this study was to determine the level of knowledge of patients with MS of Covid 19 during the corona epidemic in Jahrom in 2021.
Methods: This descriptive cross-sectional census study was performed on 191 patients with definite multiple sclerosis in Jahrom in 2021. Data collection tools included a demographic information questionnaire and a standard questionnaire for MS patients’ knowledge of Covid 19. Questionnaire information was collected in SPSS software version 21 and collected using descriptive and inferential statistical indicators.
Results: Of 191 patients with MS during coron pandemic, 6.3% of them had coronary artery disease. The mean score of MS patients was (80.7%). There was a significant relationship between demographic variables such as gender, education and number of households with patients’ knowledge (P<0.05). The highest level of awareness was observed in men, patients with postgraduate education and patients with a large number of two-person households and in government employees with excellent economic status. The majority of patients considered the disease phase to be pandemic and the corona to be rapidly transmitted from person to person and its symptoms to be persistent fever and cough. The majority of patients also believed in the protective role of gloves and masks and the use of shields in preventing coronary heart disease.
Conclusion: Patients with MS have a good understanding of this stage of the Covid 19 pandemic, while about 10% of them do not follow the quarantine rules completely. Therefore, training programs can be considered for these people who are at higher risk for Covid 19 infection.
Methods: This descriptive cross-sectional census study was performed on 191 patients with definite multiple sclerosis in Jahrom in 2021. Data collection tools included a demographic information questionnaire and a standard questionnaire for MS patients’ knowledge of Covid 19. Questionnaire information was collected in SPSS software version 21 and collected using descriptive and inferential statistical indicators.
Results: Of 191 patients with MS during coron pandemic, 6.3% of them had coronary artery disease. The mean score of MS patients was (80.7%). There was a significant relationship between demographic variables such as gender, education and number of households with patients’ knowledge (P<0.05). The highest level of awareness was observed in men, patients with postgraduate education and patients with a large number of two-person households and in government employees with excellent economic status. The majority of patients considered the disease phase to be pandemic and the corona to be rapidly transmitted from person to person and its symptoms to be persistent fever and cough. The majority of patients also believed in the protective role of gloves and masks and the use of shields in preventing coronary heart disease.
Conclusion: Patients with MS have a good understanding of this stage of the Covid 19 pandemic, while about 10% of them do not follow the quarantine rules completely. Therefore, training programs can be considered for these people who are at higher risk for Covid 19 infection.
Type of Study: Original Article |
Subject:
مدیریت بهداشتی
Received: 2021/07/23 | Accepted: 2021/08/21 | Published: 2021/08/1
Received: 2021/07/23 | Accepted: 2021/08/21 | Published: 2021/08/1
References
1. Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020; 55(6):105948. [DOI:10.1016/j.ijantimicag.2020.105948] [PMID] [PMCID] [DOI:10.1016/j.ijantimicag.2020.105948]
2. Zhao S, Chen H. Modeling the epidemic dynamics and control of COVID-19 outbreak in China. Quant Biol. 2020; 1-19. [DOI: 10.1007/s40484-020-0199-0] [PMCID] [PMID] [DOI:10.1007/s40484-020-0199-0]
3. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382:1708-20. https://www.nejm.org/doi/full/10.1056/nejmoa2002032 [DOI:10.1056/NEJMoa2002032]
4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395(10229):1054-62. [DOI:10.1016/S0140-6736(20)30566-3] [PMID] [PMCID] [DOI:10.1016/S0140-6736(20)30566-3]
5. Takian A, Raoofi A, Kazempour-Ardebili S. COVID-19 battle during the toughest sanctions against Iran. Lancet. 2020; 395(10229):1035-6. [DOI:10.1016/S0140-6736(20)30668-1] [DOI:10.1016/S0140-6736(20)30668-1]
6. Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. Global epidemiology of coronavirus disease 2019: Disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020: 55(4):105946. [DOI:10.1016/j.ijantimicag.2020.105946] [PMID] [PMCID] [DOI:10.1016/j.ijantimicag.2020.105946]
7. Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, et al. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019; 92(10):e1029-40. [DOI:10.1212/WNL.0000000000007035] [PMID] [PMCID] [DOI:10.1212/WNL.0000000000007035]
8. Ebrahimi H, Hassankhani H, Namdar H, Khodadadi E, Ferguson C. Experiences of Iranian family caregivers supporting individuals with multiple sclerosis: A qualitative study. Int J Med Res Health Sci. 2016; 5(9):174-82. https://www.ijmrhs.com/medical-research/experiences-of-iranian-family-caregivers-supporting-individuals-with-multiplesclerosis-a-qualitative-study.pdf [DOI:10.5455/jrmds.2017513]
9. Ghasemi N, Razavi S, Nikzad E. Multiple Sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017; 19(1):1-10. [DOI:10.22074/cellj.2016.4867] [PMID] [PMCID]
10. Compston A, Coles A. Multiple sclerosis. Lancet. 2008; 372(9648):1502-17. [DOI:10.1016/S0140-6736(08)61620-7] [DOI:10.1016/S0140-6736(08)61620-7]
11. Hosseinzadeh A, Baneshi MR, Sedighi B, Kermanchi J, Haghdoost AA. Incidence of multiple sclerosis in Iran: A nationwide, population-based study. Public Health. 2019; 175:138-44. [DOI:10.1016/j.puhe.2019.07.013] [PMID] [DOI:10.1016/j.puhe.2019.07.013]
12. Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, et al. Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies. JAMA Neurol. 2020; 77(2):184-91. [DOI:10.1001/jamaneurol.2019.3365] [PMID] [PMCID] [DOI:10.1001/jamaneurol.2019.3365]
13. Karamyan A, Dünser MW, Wiebe DJ, Pilz G, Wipfler P, Chroust V, et al. Critical illness in patients with multiple sclerosis: A matched case-control study. PLoS One. 2016; 11(5):e0155795. [DOI:10.1371/journal.pone.0155795] [PMID] [PMCID] [DOI:10.1371/journal.pone.0155795]
14. Montgomery S, Hillert J, Bahmanyar S. Hospital admission due to infections in multiple sclerosis patients. Eur J Neurol. 2013; 20(8):1153-60. [DOI:10.1111/ene.12130] [PMID] [DOI:10.1111/ene.12130]
15. Steelman AJ. Infection as an environmental trigger of Multiple Sclerosis disease exacerbation. Front Immunol. 2015; 6:520. [DOI:10.3389/fimmu.2015.00520] [PMID] [PMCID] [DOI:10.3389/fimmu.2015.00520]
16. Societa Italiana di Neurologia (SIN). [Indicazioni sulla gestione del paziente con SM nel corso di epidemia da Covid 19 (Italian)] [Internet]. 2021. Available from: https://www.aism.it/sites/default/files/ComunicazioneGdSSINSM-Coronavirus.pdf
17. Panitch HS. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol. 1994; 36(suppl 1):S25-8. [DOI:10.1002/ana.410360709] [PMID] [PMCID] [DOI:10.1002/ana.410360709]
18. Sahraian MA, Gheini MR, Rezaeimanesh N, Ghajarzadeh M, Naser Moghadasi A. Knowledge regarding COVID-19 pandemic in patients with Multiple Sclerosis (MS): A report from Iran. Mult Scler Relat Disord. 2020; 42:102193. [DOI:10.1016/j.msard.2020.102193] [PMID] [PMCID] [DOI:10.1016/j.msard.2020.102193]
19. Dehghan A, Memarian R. Abundance of stress, anxiety and depression in Multiple Sclerosis patients. Alborz University Medical Journal. 2013; 2(2):82-8. [DOI:10.18869/acadpub.aums.2.2.82] [DOI:10.18869/acadpub.aums.2.2.82]
20. Talaat F, Ramadan I, Aly S, Hamdy E. Are Multiple Sclerosis patients and their caregivers more anxious and more committed to following the basic preventive measures during the COVID-19 pandemic? Mult Scler Relat Disord. 2020; 46:102580. [DOI:10.1016/j.msard.2020.102580] [PMID] [PMCID] [DOI:10.1016/j.msard.2020.102580]
21. Ghajarzadeh M, Naser Moghadasi A, Navardi S, Mohammadi A, Hamtaee S, et al. Attitude and knowledge of patients with Multiple Sclerosis (MS) About COVID-19 as provided by physicians. Arch Neurosci. 2021; 8(1):e112867. [DOI:10.5812/ans.112867] [DOI:10.5812/ans.112867]
22. Shaygannejad V, Afshari-Safavi A, Hatef B. Assessment of mental health, knowledge, and attitude of patients with Multiple Sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus. Neurol Sci. 2021; 42(7):2891-901. [DOI:10.1007/s10072-020-04905-5] [PMID] [PMCID] [DOI:10.1007/s10072-020-04905-5]
23. Yoo JH, Hong ST. The outbreak cases with the novel coronavirus suggest upgraded quarantine and isolation in Korea. J Korean Med Sci. 2020; 35(5):e62. [DOI:10.3346/jkms.2020.35.e62] [PMID] [PMCID] [DOI:10.3346/jkms.2020.35.e62]
24. Goh KT, Cutter J, Heng BH, Ma S, Koh BKW, Kwok C, et al. Epidemiology and control of SARS in Singapore. Ann Acad Med Singap. 2006; 35(5):301-16. [PMID]
25. Wijnands JMA, Zhu F, Kingwell E, Fisk JD, Evans C, Marrie RA, et al. Disease-modifying drugs for Multiple Sclerosis and infection risk: A cohort study. J Neurol Neurosurg Psychiatry. 2018; 89(10):1050-6. [DOI:10.1136/jnnp-2017-317493] [PMID] [DOI:10.1136/jnnp-2017-317493]
26. Solaro C, Trabucco E, Signori A, Martinelli V, Radaelli M, Centonze D, et al. Depressive symptoms correlate with disability and disease course in Multiple Sclerosis patients: An Italian multi-center study using the beck depression inventory. PLoS One. 2016; 11(9):e0160261. [DOI:10.1371/journal.pone.0160261] [PMID] [PMCID] [DOI:10.1371/journal.pone.0160261]
27. Mateen FJ, Rezaei S, Alakel N, Gazdag B, Kumar AR, Vogel A. Impact of COVID-19 on U.S. and Canadian neurologists' therapeutic approach to Multiple Sclerosis: A survey of knowledge, attitudes, and practices. J Neurol. 2020; 267(12):3467-75. [DOI:10.1007/s00415-020-10045-9] [PMID] [PMCID] [DOI:10.1007/s00415-020-10045-9]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2008-1375
pISSN: 1735-7799
Email: journal[at]muq.ac.ir
j.mua.ac[at]gmail.com
